VEGFA and glaucoma: They hypothesized that PIGF may be a potential therapeutic target for glaucoma surgery, and proposed that a combination of optimal-dosing anti-PIGF with suboptimal-dosing anti-VEGF may be more effective at reducing scar formation compared to monotherapy with either agent alone.